reports
EXL Schedules Third Quarter 2025 Financial Results Conference Call
EXL Schedules Third Quarter 2025 Financial Results Conference Call NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI company, will release financial results for the third quarter ended Sept. 30, 2025, on Tuesday, Oct 28, 2025, after the market closes. An earnings news release, investor fact sheet and presentation will be published on the company’s investor relations website offering an overview of the financial results. The company will host a conference call at 10:00 a.m. EDT the following day, Wednesday, Oct. 29, 2025, with Chair...
EXL unveils EXLdata.ai with launch partner Databricks: First-of-its-ki...
EXL unveils EXLdata.ai with launch partner Databricks: First-of-its-kind agentic AI-native suite of data solutions to solve enterprises’ biggest challenge in making data ready for AI Unifies complex data ecosystems to accelerate AI in the workflow NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- [NASDAQ: EXLS] is unlocking the data foundation to make AI real for enterprises with its newly unveiled agentic AI suite of data solutions, . In partnership with Databricks, the Data and AI company, this suite of data solutions tackles the top barrier to AI adoption by making enterprise data usable ...
EXL Named a Leader in NelsonHall’s 2025 NEAT Evaluation for Property &...
EXL Named a Leader in NelsonHall’s 2025 NEAT Evaluation for Property & Casualty Operations: Analytics & AI NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- [NASDAQ: EXLS], a global data and AI company, has been recognized as a Leader by NelsonHall in its 2025 NEAT Evaluation for P&C Operations: Analytics & AI. The recognition highlights EXL’s commitment to innovation and its ability to embed powerful analytics and AI-driven solutions into the enterprise workflows of the world’s leading property and casualty (P&C) insurers. The leverages the NelsonHall Vendor Evaluation and Assessment Tool ...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
SCHL SCHOLASTIC CORPORATION
MRCY MERCURY SYSTEMS INC.
LPTH LIGHTPATH TECHNOLOGIES INC. CL A
KURA KURA ONCOLOGY INC.
JACK JACK IN THE BOX INC.
INTC INTEL CORPORATION
HELE HELEN OF TROY LIMITED
CROX CROCS INC.
AIR AAR CORP.
UNFI UNITED NATURAL FOODS INC.
LINK INTERLINK ELECTRONICS
SRRK SCHOLAR ROCK HOLDING CORPORATION
STOK STOKE THERAPEUTICS
IMTX IMMATICS N V (A)
KYMR KYMERA THERAPEUTICS
LRMR LARIMAR THERAPEUTICS INC
COGT COGENT BIOSCIENCES INC
RLAY RELAY THERAPEUTICS
HIMS HIMS AND HERS HEALTH INC (A)
VERA VERA THERAPEUTICS INC
TNGX TANGO THERAPEUTICS INC
DSGN DESIGN THERAPEUTICS INC
GLUE MONTE ROSA THERAPEUTICS INC
MBC_w MASTERBRAND INC
IRON DISC MEDICINE INC
CTNM CONTINEUM THERAPEUTICS INC
PACS PACS GROUP INC
ZBIO ZENAS BIOPHARMA INC.
UPB UPSTREAM BIO INC
MIR MIRION TECHNOLOGIES INC
SION SIONNA THERAPEUTICS INC
KLRS KALARIS THERAPEUTICS INC
BKTI BK TECHNOLOGIES CORP
EMPG EMPRO GROUP INC
EXL Recognized as a Leader by Everest Group in its Healthcare Data, An...
EXL Recognized as a Leader by Everest Group in its Healthcare Data, Analytics and AI Services PEAK Matrix® Assessment 2025 NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- [NASDAQ: EXLS], a global data and AI company, has been recognized by Everest Group as a Leader in its Healthcare Data, Analytics and AI Services PEAK Matrix® Assessment 2025. highlights EXL’s comprehensive portfolio of healthcare analytics solutions and platform solutions. The report cites EXL’s focus on data, analytics as well as its deep domain expertise and robust partner ecosystem as key strengths. “In healthcare, m...
Kymera Therapeutics Announces Late-Breaking Oral Presentations on KT-6...
Kymera Therapeutics Announces Late-Breaking Oral Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the European Academy of Dermatology & Venereology and European Respiratory Society Congresses Featured presentations showcase the positive Phase 1 healthy volunteer trial results supporting KT-621’s oral, dupilumab-like profile KT-621 BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) patients on track to report data in 4Q25 KT-621 Phase 2b trials in AD and asthma on track to initiate in 4Q25 and 1Q26, respectively WATERTOWN, Mass., Sept. 17, 2025 (GLOBE ...
ExlService Holdings Inc: 1 director
A director at ExlService Holdings Inc sold 8,000 shares at 43.760USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Hooker Furnishings Reports Fiscal 2026 Second Quarter Results
Hooker Furnishings Reports Fiscal 2026 Second Quarter Results Company reaffirms dividend, maintains profitability focus, and positions for growth MARTINSVILLE, Va., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (NASDAQ-GS: HOFT) (“Hooker” or the “Company”), a global leader in home furnishings, today reported operating results for its fiscal 2026 second quarter ended August 3, 2025. Executive Commentary “Hooker Furnishings is taking decisive steps to return the business to profitability. Our cost-reduction initiatives and focus on growth initiatives have positioned ...
EXL teams with InsureMO to help insurers modernize data architecture a...
EXL teams with InsureMO to help insurers modernize data architecture and speed AI integration New offering enables insurers to launch new products faster, reduce operational costs and modernize core systems without disruption SYDNEY and NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- [NASDAQ: EXLS], a global data and AI company, has announced a teaming agreement with , the world’s leading insurance middleware platform. This collaboration is designed to provide insurers worldwide with a faster, more flexible path to core system modernization, AI integration and digital transformation. By ...
Hooker Furnishings Declares Quarterly Dividend
Hooker Furnishings Declares Quarterly Dividend MARTINSVILLE, Va., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (Nasdaq-GS: HOFT) announced that on September 9, 2025, its board of directors declared a quarterly cash dividend of $0.23 per share, payable on September 30, 2025, to shareholders of record on September 19, 2025. Hooker Furnishings Corporation, in its 101st year of business, is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home décor for the residential...
EXL releases sixth annual Sustainability Report
EXL releases sixth annual Sustainability Report Employee volunteering and giving saw participation from more than 31,000 team members NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- [NASDAQ: EXLS], a global data and AI company, announced that it has published its sixth annual , which highlights its progress across key sustainability performance metrics. “At EXL, sustainability is embedded into our culture to ensure that we are systematically creating efficiencies and returns for our business that benefit the communities and societies in which we live and work,” said Rohit Kapoor, EXL’s c...
Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Co...
Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Corporate Secretary WATERTOWN, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the appointment of Brian Adams, JD, as Chief Legal Officer and Corporate Secretary. Mr. Adams is a highly accomplished legal executive with nearly two decades of leadership in the life sciences, spanning corporate development, strategic planning, and governance. He will lead Kymera’s l...
CORRECTION - Hooker Furnishings to Host Second Quarter Earnings Call S...
CORRECTION - Hooker Furnishings to Host Second Quarter Earnings Call September 11th MARTINSVILLE, Va., Aug. 31, 2025 (GLOBE NEWSWIRE) -- CORRECTED VERSION: On August 29, 2025, the Company issued a press release with an incorrect registration link and this updated release provides the correct link. Corrected release follows in full: Hooker Furnishings Corporation (Nasdaq-GS: HOFT) will present its fiscal 2026 second quarter financial results via teleconference and live internet web cast on Thursday morning, September 11, 2025 at 9:00 AM Eastern Time. A live webcast of the call will be a...
Hooker Furnishings to Host Second Quarter Earnings Call September 11th
Hooker Furnishings to Host Second Quarter Earnings Call September 11th MARTINSVILLE, Va., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (Nasdaq-GS: HOFT) will present its fiscal 2026 second quarter financial results via teleconference and live internet web cast on Thursday morning, September 11, 2025 at 9:00 AM Eastern Time. A live webcast of the call will be available on the Investor Relations page of the Company’s website at and archived for replay. To access the call by phone, participants should go to this link ) and you will be provided with dial-in details. To a...
EXL to participate in Citi Global TMT Conference in New York
EXL to participate in Citi Global TMT Conference in New York NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc., (NASDAQ: EXLS) announced today that Vivek Jetley, president and head of Insurance, Healthcare and Life Sciences and Maurizio Nicolelli, chief financial officer, will present at the Citi Global TMT Conference on Wednesday, Sept. 3, 2025, at 4:10 p.m. Eastern Time. A live audio webcast of the presentation will be available on the events page of EXL’s investor . About ExlService Holdings, Inc.EXL (NASDAQ: EXLS) is a global data and AI company that offers servic...
Kymera Therapeutics to Participate in Upcoming September Investor Conf...
Kymera Therapeutics to Participate in Upcoming September Investor Conferences WATERTOWN, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events: Citi 2025 Biopharma Back to School Conference in Boston, MA on September 3 at 10:30 a.m. ET;Wells Fargo 2025 Healthcare Conference in Boston, MA on September 4 at 9:30 a.m. ET;Morgan Stanley 23rd Annu...
EXL opens new Headquarters for International Business and Launches AI ...
EXL opens new Headquarters for International Business and Launches AI Innovation Lab in Dublin Company plans to hire 60 new AI-skilled roles, as part of its goal to create 200 high-impact jobs DUBLIN and NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- [NASDAQ: EXLS], a global data and AI company, has opened its new headquarters for international business in Dublin’s Docklands. An Tánaiste Simon Harris TD hosted the ribbon-cutting ceremony with EXL Chairman and CEO Rohit Kapoor, The Lord Mayor of Dublin Councillor Ray McAdam, Professor Colin Scott, Deputy President and Vice President of Aca...
Kymera Therapeutics Announces Second Quarter 2025 Financial Results an...
Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update Reported positive KT-621 (STAT6) Phase 1 healthy volunteer data surpassing Kymera’s target product profile, and further validating its oral, dupilumab-like profile KT-621 BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) patients on track to report data in 4Q25 Doses selected for KT-621 Phase 2b trials in AD and asthma, which are on track to initiate in 4Q25 and 1Q26, respectively KT-579 (IRF5) IND-enabling studies ongoing, with Phase 1 clinical tri...
Seneca Foods Reports Sales and Earnings for the Three Months Ended Jun...
Seneca Foods Reports Sales and Earnings for the Three Months Ended June 28, 2025 FAIRPORT, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Seneca Foods Corporation (NASDAQ: SENEA, SENEB) today announced financial results for the three months ended June 28, 2025. Executive Summary (vs. year-ago, year-to-date results): Net sales for the first quarter of fiscal 2026 totaled $297.5 million compared to $304.7 million for the first quarter of fiscal 2025. The year-over-year decrease of $7.2 million was driven by lower sales volumes, partially offset by higher selling prices and the impact of ...
Kymera Therapeutics to Report Second Quarter 2025 Financial Results on...
Kymera Therapeutics to Report Second Quarter 2025 Financial Results on August 11, 2025 WATERTOWN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report second quarter 2025 financial results on August 11, 2025. The Company will host a video conference call and webcast at 8:30 a.m. ET that day. To join the video call or view the livestreamed webcast, please register via , or visit “” in the Investors section of the Company’s website at . A r...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.